On Monday, Shares of PMFG, Inc. (NASDAQ:PMFG), skyrocketed 38.96% to $6.42.
PMFG, declared that Peter Burlage, Chairman and Chief Executive Officer, and Ron McCrummen, Chief Financial Officer, will talk about the Company’s results for the quarter ended March 28, 2015, during a conference call planned for Thursday, May 7, 2015, at 9:30 a.m. EDT. The Company’s financial results for the third quarter are planned to be released before the open of the market on May 7, 2015.
PMFG, Inc. provides custom-engineered systems and products primarily for the natural gas infrastructure, power generation, and oil refining and petrochemical processing markets worldwide. The company operates in two segments, Process Products and Environmental Systems.
At the end of Monday’s trade, Shares of BroadSoft, Inc. (NASDAQ:BSFT), jumped 16.79% to $37.63, hitting its highest level.
BroadSoft, declared financial results for the quarter ended March 31, 2015.
Financial Highlights for the First Quarter of 2015
- Total revenue raised 27% year-over-year to $55.7 million
- GAAP gross profit equaled 72% of total revenue; non-GAAP gross profit equaled 76% of total revenue
- GAAP income from operations totaled $0.1 million; non-GAAP income from operations totaled $7.7 million or 14% of revenue
- GAAP basic and diluted net loss per share equaled $(0.07) per common share; non-GAAP diluted earnings per share equaled $0.24 per common share.
Results for the three months ended March 31, 2015
Total revenue rose to $55.7 million in the first quarter of 2015, an enhance of 27% contrast to $43.9 million in the first quarter of 2014.
Net loss for the first quarter of 2015 was $(2.0) million, or $(0.07) per basic and diluted common share, contrast to net loss of $(7.5) million, or $(0.26) per basic and diluted common share in the first quarter of 2014.
On a non-GAAP basis, net income in the first quarter of 2015 was $7.3 million, or $0.24 per diluted common share, contrast to non-GAAP net income of $2.2 million, or $0.07 per diluted common share, in the first quarter of 2014.
BroadSoft, Inc. provides software and services that enable mobile, fixed-line, and cable service providers to deliver hosted or cloud-based unified communications (UC), and other voice and multimedia services over Internet protocol (IP) based networks in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Array BioPharma, Inc. (NASDAQ:ARRY), ended its last trade with 13.05% gain, and closed at $7.15.
Array BioPharma, stated results for the third quarter of its fiscal year ending June 30, 2015.
Array ended the quarter with $191 million in cash, cash equivalents and marketable securities. Revenue for the third quarter of fiscal 2015 was $6.6 million, contrast to $7.8 million for the same period last year. Cost of partnered programs for the third quarter of fiscal 2015 was $12.1 million, contrast to $10.8 million for the same period last year. Research and development expense was $11.8 million, contrast to $14.1 million in the same preceding year period. Net income for the third quarter was $58.3 million, or $0.37 per share (diluted), contrast to a net loss of $24.9 million, or ($0.20) per share (diluted), for the same period in fiscal 2014. As part of the Novartis transaction, Array received an $85 million cash payment and extinguished net liabilities of $21.6 million which resulted in an enhance in working capital of $106.6 million. The extinguished liabilities will not impact ending cash, cash equivalents and marketable securities balance as of March 31, 2015. Of this amount, $6.6 million will be treated as deferred revenue. Also during the quarter, Array reached a third party agreement to complete the Novartis transactions for a net consideration of $25 million.
For the nine months ended March 31, 2015, revenue was $39.6 million, contrast to $36.1 million for the same period in fiscal 2014. Net income for the nine months ended March 31, 2015, was $22.1 million, or $0.16 per share (diluted), contrast to a net loss of $57.0 million, or ($0.47) per share (diluted), in the comparable preceding year period.
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific.
Finally, Image Sensing Systems, Inc. (NASDAQ:ISNS), closed at $3.11, with 12.68% gain.
Image Sensing Systems, will distribute its earnings results for the first quarter ended March 31, 2015, after the close of trading on Thursday, May 14, 2015.
Following the release, the company will hold a conference call at 3:45 p.m. central time. Dale Parker, CEO, COO and CFO, and Richard Ehrich, Controller, will review Image Sensing Systems’ performance for the quarter. To take part, dial 888-576-4387 and reference conference ID 6509298. Please dial in at least 10 minutes preceding to the call.
Image Sensing Systems, Inc. develops and markets software-based computer enabled detection products and solutions for the intelligent transportation systems industry, and adjacent security and law enforcement markets.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
